drugset / Trial / NCT07092007
NWRD09 for HPV-16 Related Intraepithelial Neoplasia and Cervical Cancer
NaSequentialOpen-labelTreatment
Summary
This is a single-arm, open label, two cohorts, multi-center clinical study to evaluate the safety and efficacy of HPV-16 targeted mRNA vaccine (NWRD09) in HPV-16 related Cervical, vaginal, and vulvar intraepithelial neoplasia (LSIL and HSIL) patients (cohort A) and HPV-16 related cervical cancer patients (cohort B).
Timeline
- Start
- 2024-06-05
- Primary completion
- 2025-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | NWRD09 | Messenger RNA (mRNA) | — | Intramuscular |